À retenir
In 199 Canadian National Team athletes, the Athlete Sleep Screening Questionnaire agreed well with a sleep medicine physician's rating (Cohen's kappa = 0.84), with 81% sensitivity and 93% specificity in a randomized subset of 46. That subset is small, and the claim that sleep improved afterwards comes from a group without a comparison arm.
Study design
Validation : étude/revue
Reading basis
Published abstract
Reading focus
Reference & error
Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.
Question de recherche
General sleep questionnaires have not worked well in athletes, so the Athlete Sleep Screening Questionnaire (ASSQ) was built for them. Its initial validation was done, but not whether it agrees with a clinician's judgement. The authors tested that clinical validity.
Population et méthode
Validation study. Canadian National Team athletes (N = 199; mean age 24.0 ± 4.2 years, 62% females; from 23 sports) completed the ASSQ. A randomized subset (N = 46) completed the ASSQ at times 2 and 3 and had a clinical sleep interview with a sleep medicine physician (SMP), who rated each athlete's category of clinical sleep problem and gave recommendations to improve sleep. The SMP category was compared with the ASSQ result. The abstract does not describe the recommendations in detail or how sleep improvement was measured.
Résultats
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1The questionnaire was consistent and repeatable: internal consistency (Cronbach's alpha) was 0.74 and test-retest reliability was r = 0.86, both described as acceptable.
- 2Agreement with the physician was good (Cohen's kappa = 0.84). Sensitivity was 81%, specificity 93%, positive predictive value 87% and negative predictive value 90%.
- 325.1% of athletes were identified as having clinically relevant sleep disturbances needing further clinical sleep assessment.
- 4Sleep improved from baseline (time 1) to after the recommendations (time 3), though the abstract gives no numbers for this change.
Limites et incertitude
- 1The clinical comparison rests on only 46 athletes, so the sensitivity and specificity estimates are imprecise; the abstract gives no confidence intervals.
- 2Participants were national team athletes in Canada, so results may not apply to recreational athletes or other countries.
- 3Sleep improvement was assessed without a control group not receiving recommendations, so it cannot be attributed to the recommendations themselves.
- 4This reading is based on the abstract only.
Mise en perspective
For teams, a short screening questionnaire can flag which athletes probably need a proper sleep assessment, which seems to be what this tool does reasonably well. It is a screen, not a diagnosis, and anyone with persistent sleep problems should see a clinician.
Vos données
If you train seriously, a wearable's sleep duration and consistency can sit alongside a questionnaire score as a reason to look closer, but the study did not test wearables. Compare your own sleep over several weeks on one device, not single nights.
Comprendre ce type de preuve
Agreement is specific to the device, firmware, reference, population and setting. Correlation is not agreement, and validating a metric is not proof of diagnostic or treatment benefit.
Résumé structuré des auteurs English
Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.
Background
Previous research has established that general sleep screening questionnaires are not valid and reliable in an athlete population. The Athlete Sleep Screening Questionnaire (ASSQ) was developed to address this need. While the initial validation of the ASSQ has been established, the clinical validity of the ASSQ has yet to be determined. The main objective of the current study was to evaluate the clinical validity of the ASSQ.
Methods
Canadian National Team athletes (N = 199; mean age 24.0 ± 4.2 years, 62% females; from 23 sports) completed the ASSQ. A subset of athletes (N = 46) were randomized to the clinical validation sub-study which required subjects to complete an ASSQ at times 2 and 3 and to have a clinical sleep interview by a sleep medicine physician (SMP) who rated each subjects' category of clinical sleep problem and provided recommendations to improve sleep. To assess clinical validity, the SMP category of clinical sleep problem was compared to the ASSQ.
Results
The internal consistency (Cronbach's alpha = 0.74) and test-retest reliability (r = 0.86) of the ASSQ were acceptable. The ASSQ demonstrated good agreement with the SMP (Cohen's kappa = 0.84) which yielded a diagnostic sensitivity of 81%, specificity of 93%, positive predictive value of 87%, and negative predictive value of 90%. There were 25.1% of athletes identified to have clinically relevant sleep disturbances that required further clinical sleep assessment. Sleep improved from time 1 at baseline to after the recommendations at time 3.
Conclusions
Sleep screening athletes with the ASSQ provides a method of accurately determining which athletes would benefit from preventative measures and which athletes suffer from clinically significant sleep problems. The process of sleep screening athletes and providing recommendations improves sleep and offers a clinical intervention output that is simple and efficient for teams and athletes to implement.
Sources et attribution
The Clinical Validation of the Athlete Sleep Screening Questionnaire: an Instrument to Identify Athletes that Need Further Sleep Assessment.
Bender AM, Lawson D, Werthner P, Samuels CH.
Sports medicine - open · 2018-06-04
DOI: 10.1186/s40798-018-0140-5 ↗PubMed · 29869021 ↗Europe PMC · Licence indiquée: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée
Sources vérifiées 2026-11-01
Guides pratiques
À lire ensemble
Exercise improved sleep-quality scores in adults 45 and older with sleep disorders
Pooling 23 randomized trials with 1,478 adults aged 45 to 77 who had sleep disorders, exercise improved Pittsburgh Sleep Quality Index scores (SMD 0.62, 95% CI 0.40–0.83), and aerobic exercise showed the largest effect in the network analysis (SMD 1.34, 95% CrI 0.86–1.82). Certainty was low to moderate, the outcomes were questionnaires, and the best weekly dose of about 539 MET-min/week is a model estimate, not a prescription.
Journal of Exercise Science & Fitness
Sleep regularity tracked mortality more closely than sleep duration in 60,977 UK adults
Among 60,977 UK Biobank adults who wore a wrist accelerometer for a week, the most regular fifth of sleepers had a fully adjusted all-cause mortality HR of 0.70 (95% CI 0.59–0.83) against the least regular fifth, over about 6.3 years and 1859 deaths. Regularity fitted the data better than sleep duration, but the study is observational and rests on one week of sleep data.
Sleep
Sleep extension cut daily energy intake by about 270 kcal in adults with overweight
In 80 adults with overweight who usually slept under 6.5 hours, two weeks of sleep-extension counselling added about 1.2 hours of sleep and lowered measured energy intake by 270.4 kcal/d versus control (95% CI −393.4 to −147.4). The trial was short, single-centre and in a narrow group, so it does not show lasting weight loss or any benefit for people who already sleep enough.
JAMA Internal Medicine
Six hours or less of sleep at 50 and 60 linked to higher dementia risk
In 7959 British civil servants followed for about 25 years, sleeping six hours or less at age 50 (HR 1.22, 95% CI 1.01–1.48) or age 60 (HR 1.37, 1.10–1.72) was linked to a higher dementia rate than sleeping seven hours, and persistent short sleep gave an HR of 1.30 (1.00–1.69). Sleep was mostly self-reported and the study is observational, so early brain disease or other factors may explain part of the link.
Nature Communications

